DarioHealth Corp. announced that Steven Nelson will cease serving as President and Chief Commercial Officer effective September 1, 2026, with his employment terminating on September 30, 2026. The separation agreement includes payment of earned wages, continued health insurance through the separation date, and COBRA reimbursement of $2,600 monthly for up to three months. Unvested equity awards will expire upon termination. Nelson will transition into a consulting role effective October 1, 2026, providing advisory services through December 31, 2027, in exchange for 30,000 shares of restricted common stock vesting on the first anniversary of the grant date. DarioHealth Corp. operates in the digital health industry, providing remote patient monitoring and chronic disease management solutions.
